Latest Hba1c Podcast Episodes
1. When and how to initiate insulin
ASCEND Talking Diabetes - November 26, 2020 13:00 - 7 minutesProfessor Simon Heller provides guidance to initiating basal insulin and managing hypoglycaemia. Learning objective: Following this activity you will be able to confidently initiate basal insulin
2. How to support people earlier in living with diabetes
ASCEND Talking Diabetes - November 26, 2020 12:00 - 9 minutesProfessor Michael Vallis and Joe Dias discuss how to identify and use teachable moments to help people with diabetes achieve glycaemic control earlier. Learning objective: Following this activity, you will be more confident in motivating patients to change their behaviour
3. Sulphonylureas and managing hypoglycaemia in practice
ASCEND Talking Diabetes - November 26, 2020 12:00 - 9 minutesP Professor Chan discusses SU-related hypoglycaemia and provides practical advice for its management. Learning objective: Following this activity, you will be able to better reduce risk of SU-induced hypoglycaemia and support patients in managing it.
4. Why should I treat more intensively earlier?
ASCEND Talking Diabetes - November 26, 2020 11:00 - 6 minutesProfessor Knop outlines why treating early and intensifying treatment as appropriate is likely to reduce diabetes-related complications. Learning objectives: Following this activity, you will be able to better discuss the link between loss of beta cell function, glycaemic control and risk of co...
7. An exciting time ahead for primary care physicians in diabetes
ASCEND Talking Diabetes - November 25, 2020 10:00 - 3 minutesProfessor Kamlesh Khunti discusses what the key characteristics of therapeutic agents available in diabetes are. Learning objective: Following this activity, you will be able to adopt an approach to treatment that considers all available options
8. Discussing injectables with people living with diabetes
ASCEND Talking Diabetes - November 25, 2020 10:00 - 8 minutesProfessor Liebl discusses best communication approaches for insulins and GLP-1 RAs. Learning objective: Following this activity, you will be able to better overcome the barriers to initiating injectables and discuss the differences between insulins and GLP-1 RAs.
10. Which people with type 2 diabetes would benefit from SGLT-2 inhibitors and GLP-1 receptor agonists?
ASCEND Talking Diabetes - November 25, 2020 10:00 - 11 minutesListen to Professor Liebl outline when and how he uses these modern agents. Learning objective: Following this activity, you will be able to confidently identify individuals in whom SGLT-2 inhibitors and GLP-1 receptor agonists are likely to be the preferred therapeutic option after metformin.
9. How I have changed my practice following new guidelines
ASCEND Talking Diabetes - November 25, 2020 10:00 - 8 minutesClinical practice in type 2 diabetes has changed, learn more from Professor Abrahamson. Learning objective: Following this activity, you will be able to more confidently tailor treatments for people with T2DM, particularly newer agents
11. Improving quality of life and confidence with continuous glucose monitoring
ASCEND Talking Diabetes - November 25, 2020 10:00 - 5 minutesMr Joe Dias discusses how continuous glucose monitoring can transform lives. Learning objective: Following this activity, you will be more confidently discuss the benefits of continuous glucose monitoring with people with diabetes.
5. Can GLP-1 receptor agonists and SGLT-2 inhibitors be used together?
ASCEND Talking Diabetes - November 25, 2020 10:00 - 8 minutesProfessor Knop provides advice on using these agents in combination – who would benefit most, managing potential side effects and considerations for use. Learning objectives: Following this activity, you will be able to: Confidently identify people who would benefit from this combination and be...
6. The key role of primary care in type 2 diabetes
ASCEND Talking Diabetes - November 25, 2020 10:00 - 5 minutesProfessor Xavier Cos discusses why primary care physicians are so important in diabetes management. Learning objectives: Following this activity, you will be more confident in tailoring treatment and developing a plan for all patients in your clinic.
Part 3. Treatment
Reconciling Current Diabetes Guidelines - November 05, 2010 16:15 - 5 minutesDr. Davidson addresses some of the differences between the treatment guidelines offered by the ADA, who recently updated their guidelines, and AACE guidelines, and shares a number of important insights into their practical implementation.
Part 2. Goals of Therapy
Reconciling Current Diabetes Guidelines - November 05, 2010 16:14 - 5 minutesDr. Davidson focuses on the key differences in the criteria of HbA1c goals of therapy (how and why) developed by the ADA, the American Association of Clinical Endocrinologists (AACE), and the American College of Endocrinology (ACE), and which guidelines PCPs should follow.
Part 1. Diagnosis
Reconciling Current Diabetes Guidelines - November 05, 2010 16:13 - 7 minutesJaime A. Davidson, MD, discusses guidelines and statements issued by a number of organizations, including the American Diabetes Association (ADA), addressing the diagnosis of type 2 diabetes mellitus (T2DM) and how they differ in some key aspects.
Part 5. Should Glycemic Goals Be the Same for All Patients?
Individualizing Target HbA1c Level - September 30, 2010 07:10 - 6 minutesDr. Bloomgarden reviews recent trial data (ie, ACCORD, ADVANCE, VA diabetes trial), and examines different safety issues that must be taken into account in determining how intensive a glycemic intervention be considered.
Part 4. Are There Methodologic Issues with Measuring HbA1c?
Individualizing Target HbA1c Level - September 30, 2010 07:09 - 1 minuteDr. Bloomgarden briefly synopsizes laboratory test variability with regard to measuring HbA1c levels.
Part 3. Should HbA1c Be Used in the Diagnosis of T2DM?
Individualizing Target HbA1c Level - September 30, 2010 07:08 - 3 minutesIn Part 3 of this podcast, the discussion surrounds the International Expert Committee's recommendations, which has been taken up by the American Diabetes Association, to suggest that 6.5 be used for the diagnosis of diabetes. Dr. Bloomgarden offers his thoughts on the relationship of blood sugar...
Part 2. Does HbA1c Provide a True Average Glucose Measurement with a High Degree of Accuracy in an Individual Patient?
Individualizing Target HbA1c Level - September 30, 2010 07:07 - 8 minutesDr. Bloomgarden focuses on the various factors influencing A1c, and explores the issues surrounding a
Part 1. Has HbA1c Lowering Been Incorrectly Interpreted in Current Guidelines?
Individualizing Target HbA1c Level - September 30, 2010 07:06 - 4 minutesZachary Bloomgarden, MD, discusses hemoglobin A1c (HbA1c) lowering with various drugs. In a meta-analysis done, Dr. Bloomgarden and colleagues found that there was a strong relationship between baseline glycemia and the degree of fallen blood sugar. He also touches on the concerns that the ADA g...
Related Hba1c Topics